Archford Capital Strategies’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $415K | Sell |
|
|||||
|
2025
Q2 | $379K | Buy |
|
|||||
|
2025
Q1 | $398K | Buy |
|
|||||
|
2024
Q4 | $354K | Sell |
|
|||||
|
2024
Q3 | $422K | Sell |
|
|||||
|
2024
Q2 | $519K | Hold |
|
|||||
|
2024
Q1 | $451K | Sell |
|
|||||
|
2023
Q4 | $469K | Sell |
|
|||||
|
2023
Q3 | $555K | Sell |
|
|||||
|
2023
Q2 | $674K | Buy |
|
|||||
|
2023
Q1 | $545K | Sell |
|
|||||
|
2022
Q4 | $548K | Hold |
|
|||||
|
2022
Q3 | $443K | Sell |
|
|||||
|
2022
Q2 | $539K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $489K | Sell |
|
|||||
|
2021
Q3 | $522K | Buy |
|
|||||
|
2021
Q2 | $521K | Sell |
|
|||||
|
2021
Q1 | $506K | Sell |
|
|||||
|
2020
Q4 | $2.46M | Buy |
|
|||||
|
2020
Q3 | $2.64M | Sell |
|
|||||
|
2020
Q2 | $2.57M | Sell |
|
|||||
|
2020
Q1 | $2.17M | Buy |
|
|||||
|
2019
Q4 | $2.39M | Sell |
|
|||||
|
2019
Q3 | $2.37M | Sell |
|
|||||
|
2019
Q2 | $2.23M | Sell |
|
|||||
|
2019
Q1 | $2.36M | Sell |
|
|||||
|
2018
Q4 | $2.28M | Buy |
|
|||||
|
2018
Q3 | $2.37M | Sell |
|
|||||
|
2018
Q2 | $2.36M | Sell |
|
|||||
|
2018
Q1 | $2.56M | Buy |
|
|||||
|
2017
Q4 | $930K | Sell |
|
|||||
|
2017
Q3 | $2.53M | Buy |
|
|||||
|
2017
Q2 | $2.54M | Buy |
|
|||||
|
2017
Q1 | $2.3M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $2.31M | Buy |
|
|||||
|
2016
Q2 | $635K | Sell |
|
|||||
|
2016
Q1 | $1.78M | Buy |
|
|||||
|
2015
Q4 | $2.16M | Buy |
|
|||||
|
2015
Q3 | $298K | Buy |
|
|||||
|
2015
Q2 | $297K | Sell |
|
|||||
|
2015
Q1 | $377K | Buy |
|
|||||
|
2014
Q4 | $281K | Buy |
|